As of the time of this review, several GLP1-RAs, including dulaglutide, liraglutide, exenatide, and semaglutide, have been approved to be used in the treatment of T2DM in children older than 10 years when insulin and metformin do not provide sufficient glycemic control
[2] Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, Jahoor F
At Family Allergy Clinic, our doctors will evaluate your diabetic needs and determine if this drug that has helped millions to manage their type-2 diabetes is a right fit for you
The FDA noted that it had received over 1000 reports of adverse events arising from compounded GLP-1 dosing errors and unapproved ingredients and suggested that such adverse events are likely underreported due to the limited application of federal regulations to state-licensed pharmacies